Tetrahydroisoquinoline derivatives as PPAR-alpha activators

Details Tetrahydroisoquinoline derivatives as PPAR-alpha activators Tetrahydroisoquinoline derivatives as PPAR-alpha activators

2006-01-17

2006-01-17

Davis, Zinna Northington (Department: 1625)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C546S146000

Reexamination Certificate

active

06987118

ABSTRACT:
PPAR alpha activators, pharmaceutical compositions containing such compounds and the use of such compounds to elevate certain plasma lipid levels, including high density lipoprotein-cholesterol and to lower certain other plasma lipid levels, such as LDL-cholesterol and triglycerides and accordingly to treat diseases which are exacerbated by low levels of HDL cholesterol and/or high levels of LDL-cholesterol and triglycerides, such as atherosclerosis and cardiovascular diseases, in mammals, including humans.

REFERENCES:
patent: 5658944 (1997-08-01), Chapman, Jr. et al.
patent: 2448639 (2002-12-01), None
patent: 1452521 (2004-09-01), None
patent: WO 9736579 (1997-10-01), None
patent: WO 9805331 (1998-02-01), None
patent: WO 0023407 (2000-04-01), None
patent: WO 0100603 (2001-01-01), None
patent: WO 0117994 (2001-03-01), None
patent: WO 0140207 (2001-06-01), None
patent: WO 9210468 (2002-02-01), None
patent: WO 0250047 (2002-06-01), None
patent: WO 02062774 (2002-08-01), None
patent: WO 02064139 (2002-08-01), None
patent: WO 02064549 (2002-08-01), None
patent: WO 02096904 (2002-12-01), None
patent: WO 03016265 (2003-02-01), None
patent: WO 03072102 (2003-09-01), None
English language equivalent of WO 02/096904, Dec. 2002.
English language equivalent of WO 03/016265, Feb. 2003.

Affiliated with

Also associated with

Rating

Tetrahydroisoquinoline derivatives as PPAR-alpha activators does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Tetrahydroisoquinoline derivatives as PPAR-alpha activators, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tetrahydroisoquinoline derivatives as PPAR-alpha activators will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3583664